BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 35543438)

  • 1. An NIR Fluorescence Turn-on and MRl Bimodal Probe for Concurrent Real-time in vivo Sensing and Labeling of β-Galactosidase.
    Yu Q; Zhang L; Jiang M; Xiao L; Xiang Y; Wang R; Liu Z; Zhou R; Yang M; Li C; Liu M; Zhou X; Chen S
    Angew Chem Int Ed Engl; 2023 Nov; 62(46):e202313137. PubMed ID: 37766426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An activatable fluorescence probe for rapid detection and in situ imaging of β-galactosidase activity in cabbage roots under heavy metal stress.
    Zhao K; Tan H; Fang C; Zhou Z; Wu C; Zhu X; Liu F; Zhang Y; Li H
    Food Chem; 2024 Sep; 452():139557. PubMed ID: 38728895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A
    Wang B; Huang Y; Yang D; Xu J; Zhong X; Zhao S; Liang H
    J Mater Chem B; 2023 Sep; 11(32):7623-7628. PubMed ID: 37427685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Galactosidase-activated near-infrared AIEgen for ovarian cancer imaging in vivo.
    Xu L; Gao H; Deng Y; Liu X; Zhan W; Sun X; Xu JJ; Liang G
    Biosens Bioelectron; 2024 Jul; 255():116207. PubMed ID: 38554575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A β-Galactosidase-Activated Fluorogenic Reporter for the Detection of Gastric Cancer In Vivo and in Urine.
    Yu M; Meng Z; Yi S; Chen J; Xu W; Ruan B; Wang J; Han F; Huang J
    Anal Chem; 2024 Apr; 96(16):6390-6397. PubMed ID: 38608159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Feasibility Study of Medical Fluorophore 33 as a Novel Theranostic Agent.
    Son KH; Lee DS; Park G; Jeon SY; Lee JE; Jeon HJ; Lee S; Park WJ; Shin Y; Kim SG; Lee DS; Han YR; Kim DS; Jeon YH
    ACS Appl Mater Interfaces; 2023 Oct; 15(39):45539-45548. PubMed ID: 37713436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hierarchical Self-Assembly Molecular Building Blocks as Intelligent Nanoplatforms for Ovarian Cancer Theranostics.
    Li S; Chen Q; Xu Q; Wei Z; Shen Y; Wang H; Cai H; Gu M; Xiao Y
    Adv Sci (Weinh); 2024 May; 11(17):e2309547. PubMed ID: 38408141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel GSH-activable theranostic probe containing kinase inhibitor for synergistic treatment and selective imaging of tumor cells.
    Liu C; Zhang Y; Sun W; Zhu H; Su M; Wang X; Rong X; Wang K; Yu M; Sheng W; Zhu B
    Talanta; 2023 Aug; 260():124567. PubMed ID: 37121140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fidelity-oriented fluorescence imaging probes for beta-galactosidase: From accurate diagnosis to precise treatment.
    Feng B; Chu F; Bi A; Huang X; Fang Y; Liu M; Chen F; Li Y; Zeng W
    Biotechnol Adv; 2023 Nov; 68():108244. PubMed ID: 37652143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma.
    Hepatology; 2024 May; 79(5):E150-E151. PubMed ID: 38630117
    [No Abstract]   [Full Text] [Related]  

  • 11. Galactose: A Versatile Vector Unveiling the Potentials in Drug Delivery, Diagnostics, and Theranostics.
    Battisegola C; Billi C; Molaro MC; Schiano ME; Nieddu M; Failla M; Marini E; Albrizio S; Sodano F; Rimoli MG
    Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostic Fluorescent Probes.
    Sharma A; Verwilst P; Li M; Ma D; Singh N; Yoo J; Kim Y; Yang Y; Zhu JH; Huang H; Hu XL; He XP; Zeng L; James TD; Peng X; Sessler JL; Kim JS
    Chem Rev; 2024 Mar; 124(5):2699-2804. PubMed ID: 38422393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Galactosidase-activated theranostic for hepatic carcinoma therapy and imaging.
    Maiti M; Kikuchi K; Athul KK; Kaur A; Bhuniya S
    Chem Commun (Camb); 2022 May; 58(44):6413-6416. PubMed ID: 35543438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Glutathione (GSH)-Responsive Near-Infrared (NIR) Theranostic Prodrug for Cancer Therapy and Imaging.
    Kong F; Liang Z; Luan D; Liu X; Xu K; Tang B
    Anal Chem; 2016 Jun; 88(12):6450-6. PubMed ID: 27216623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid fluorescence imaging of human hepatocellular carcinoma using the β-galactosidase-activatable fluorescence probe SPiDER-βGal.
    Ogawa S; Kubo H; Murayama Y; Kubota T; Yubakami M; Matsumoto T; Yamamoto Y; Morimura R; Ikoma H; Okamoto K; Kamiya M; Urano Y; Otsuji E
    Sci Rep; 2021 Sep; 11(1):17946. PubMed ID: 34504174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive fluorescent probe for β-galactosidase activity detection and application in ovarian tumor imaging.
    Fan F; Zhang L; Zhou X; Mu F; Shi G
    J Mater Chem B; 2021 Jan; 9(1):170-175. PubMed ID: 33230516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence optical imaging in anticancer drug delivery.
    Etrych T; Lucas H; Janoušková O; Chytil P; Mueller T; Mäder K
    J Control Release; 2016 Mar; 226():168-81. PubMed ID: 26892751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyrins and related macrocycles: Combining photosensitization with radio- or optical-imaging for next generation theranostic agents.
    Sandland J; Malatesti N; Boyle R
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():281-294. PubMed ID: 30009949
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.